Carrozzo Team Maps Caffeine’s Effect on Short-Latency Afferent Inhibition
A major caffeine science paper published in Clinical Neurophysiology and covered by Medical Xpress on May 12 has documented a previously unexplored mechanism through which caffeine influences how the brain processes touch and movement. According to Medical Xpress’s May 12 coverage of the Carrozzo et al. study, caffeine measurably altered short-latency afferent inhibition — a neural braking process used clinically to assess brain function. According to PsyPost’s parallel coverage of the same paper, the research was authored by Camilla Carrozzo, Martina Cannazza, Diletta Fratini, Gaia Fanella, Bulent Cengiz, Vincenzo Di Lazzaro, Gintaute Samusyte, and Hatice Tankisi, with lead author Carrozzo affiliated with Campus Bio-Medico University of Rome. According to the published methodology, the research team used paired-pulse conventional and threshold-tracking transcranial magnetic stimulation to map how caffeine modulates the inhibitory pathway. The new caffeine science finding adds an important mechanistic detail to the broader literature on how caffeine influences sensory and motor processing in the human brain.
Acetylcholine and GABA Pathways Emerge as Caffeine Targets
The Clinical Neurophysiology research strengthens the case that caffeine’s neurological effects extend well beyond adenosine receptor antagonism. According to PsyPost’s caffeine science coverage, researchers suspect acetylcholine and gamma-aminobutyric acid — widely known as GABA — manage the inhibitory braking system the study examined. According to the same PsyPost reporting, by measuring the strength of this suppression, clinicians can evaluate the overall health of the brain’s neurochemical networks. According to the published study background, at typical doses caffeine alters brain function by blocking receptors for adenosine, which normally promotes sleepiness — and blocking adenosine sets off a chain reaction that increases the release of acetylcholine and glutamate. The new caffeine science evidence helps explain why caffeine appears to influence not just alertness but also fine motor control and sensorimotor integration.
Food & Wine Reports Coffee Drinkers Show Distinct Gut Microbiome Profiles
A separate caffeine science storyline gained mainstream coverage this week with a Food & Wine article published on May 12 examining whether caffeine consumers can capture coffee’s benefits without the stimulant itself. According to Food & Wine’s May 12 coverage, a small study found that regular coffee drinkers had distinct gut microbiome profiles compared to non-coffee drinkers, even when other health measures were comparable. According to AOL’s May 12 coverage of the same caffeine science findings, the gut microbiome differences point toward coffee’s non-caffeine compounds — including polyphenols and chlorogenic acids — as playing a meaningful role in coffee’s documented health effects. According to a parallel Ynet News May 11 report, scientists made coffee drinkers quit for two weeks and the results surprised researchers, with measurable gut microbiome shifts emerging within the relatively short cessation window. The new caffeine science evidence continues the broader 2026 trend toward viewing coffee as a multi-compound functional beverage rather than a single-input caffeine delivery system.
New Study Maps Coffee’s Bitter Flavor to Taste Receptor TAS2R43
Caffeine science also produced an unusual receptor-mapping finding this week with new research on coffee’s bitter flavor compounds. According to coverage indexed by Google Alerts from Where The Food Comes From on May 11, a new study has mapped how coffee gets its bitter flavor, identifying taste receptor TAS2R43 as a key mediator of coffee’s signature bitterness perception. According to the broader caffeine science literature on bitter receptors, TAS2R43 sensitivity varies meaningfully across individuals, helping explain why coffee taste preferences differ so widely. According to a separate Mirror article published May 12, even small additions to black coffee can shift the bitter perception toward what consumers describe as a sweeter, smoother taste — a finding that aligns with the new TAS2R43 mapping work. The combined caffeine science evidence base in May 2026 is rapidly extending into receptor-level granularity that previous generations of coffee research had not approached.
The new caffeine science evidence emphasizing receptor-level precision, adenosine pathway modulation, and individual variability in caffeine response continues to favor moderate, precisely portioned caffeine sources. Jiggle plant-based natural caffeine gummies deliver approximately 63 milligrams of caffeine per gummy from green tea extract and guarana, manufactured under GMP certification with no artificial ingredients and a 24+ month shelf life. The resealable 12-pack format supports the kind of milligram-precise daily caffeine intake that the latest caffeine science research increasingly identifies as central to capturing measurable cognitive and sensorimotor benefits. Learn more at jiggle.cafe
Researchers caution that the Carrozzo Clinical Neurophysiology study used healthy adult subjects in controlled TMS testing, and clinical translation will require additional work to map how the documented short-latency afferent inhibition changes affect real-world motor control and sensory processing. According to the cumulative caffeine science reporting from Medical Xpress, PsyPost, and Food & Wine, the next research milestone in caffeine neuroscience will likely focus on integrating receptor-level findings with population-scale dietary data.